Blauvelt相关文献与解析，生知库 | 链接生命科学的每一步

Chen, Hao-Jing; Colburn, Kellan; Liu, Peng; Yan, Hongrui; Hou, Hanfei; Ge, Jinhao; Liu, Jin-Yu; Lehan, Phineas; Ji, Qing-Xin; Yuan, Zhiquan; Bouwmeester, Dirk; Holmes, Christopher; Gates, James; Blauvelt, Henry; Vahala, Kerry

发表日期：2026

文献求助收藏

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

特拉洛奇尤单抗治疗中重度特应性皮炎成人患者的疗效和安全性：III期试验的事后分析

期刊:American Journal of Clinical Dermatology

影响因子:8.8

doi:10.1007/s40257-025-00985-1

Mayo, Tiffany; Silverberg, Jonathan I; Armstrong, April; Guttman-Yassky, Emma; Blauvelt, Andrew; Esdaile, Ben; Kabashima, Kenji; Gooderham, Melinda; Kircik, Leon; Schneider, Shannon; Bennike, Niels; von Eyben, Rie; Martel, Britta C; Røpke, Mads A; Katoh, Norito; Alexis, Andrew F

发表日期：2026

文献求助收藏

Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis

tralokinumab治疗中重度特应性皮炎成人患者长达4年的疗效

期刊:Journal of the European Academy of Dermatology and Venereology

影响因子:8

doi:10.1111/jdv.70165

Gooderham, Melinda; Ameen, Mahreen; Hong, H Chih-Ho; Katoh, Norito; Langley, Richard G; Peris, Ketty; Reich, Kristian; Silvestre, Juan F; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-Marie; Øland, Christian Bjerregård; Blauvelt, Andrew

发表日期：2026

文献求助收藏

Cutaneous adipose tissue carries a strong inflammatory signature in patients with psoriasis

银屑病患者的皮肤脂肪组织具有强烈的炎症特征。

期刊:JCI Insight

影响因子:6.1

doi:10.1172/jci.insight.194171

Shishido-Takahashi, Naomi; Garcet, Sandra; Cueto, Inna; Hur, Hong Beom; Muscianisi, Elisa; Steadman, Jennifer; Blauvelt, Andrew; Krueger, James G

Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer.

经皮碳酸氢盐缓冲疗法可提高膀胱癌肿瘤内pH值，并引发抗肿瘤反应。

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2026.1706250

Oluwatola Oluwaseyi, Bazargan Sarah, Irrera Pietro, Chang Darwin, Thomas Ashley, Blauvelt Jamie, Beatty Matthew, Hall MacLean, Whelan Christopher J, Estrella Veronica, Rejniak Katarzyna A, Poch Michael, Fitzsimmons Nathan, Beal Ryan, Ibrahim-Hashim Arig, Pilon-Thomas Shari

High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?

高剂量、长半衰期IL-23抑制剂：银屑病治疗的下一个重大进展？

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-026-01707-z

Torres, Tiago; Blauvelt, Andrew

Poster Session I - A110 TRENDS IN SPENDING ON ADVANCED IBD THERAPIES PRESCRIBED BY GASTROENTEROLOGISTS IN MEDICARE

海报展示环节 I - A110 医疗保险中胃肠病学家开具的先进炎症性肠病 (IBD) 疗法支出趋势

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-022-00690-5

Blauvelt, Andrew; Gooderham, Melinda; Griffiths, Christopher E M; Armstrong, April W; Zhu, Baojin; Burge, Russel; Gallo, Gaia; Guo, Jiaying; Garrelts, Alyssa; Lebwohl, Mark; Raber, M; Lu, C; Ma, C; Nasser, Y; Congly, S

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study

对 Amlitelimab STREAM-AD 2b 期研究中头颈部及其他身体部位特应性皮炎的事后分析

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-025-01609-6

Reich, Adam; Blauvelt, Andrew; Weidinger, Stephan; Shi, Vivian Y; Katoh, Norito; Lynde, Charles; Gao, Xinghua; Armstrong, Nicole M; Bernigaud, Charlotte; Rahawi, Kassim

发表日期：2026

文献求助收藏

Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies

鲁索替尼乳膏按需单药治疗在轻度至中度特应性皮炎患者中显示出持续的疾病和症状控制：两项3期研究的汇总分析

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-025-01639-0

Blauvelt, Andrew; Kircik, Leon; Simpson, Eric L; Lio, Peter; Eichenfield, Lawrence F; Prajapati, Vimal H; Grewal, Parbeer; Lynde, Charles; Hong, H Chih-Ho; Sturm, Daniel; Kallender, Howard; Ren, Haobo; Paranagama, Dilan; Wong, Grace K W; Geng, Bob

发表日期：2026

文献求助收藏

Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特拉洛奇尤单抗治疗中重度特应性皮炎患者长达6年的长期安全性和有效性：开放标签扩展试验ECZTEND的最终结果

期刊:Dermatology and Therapy

影响因子:4.2

doi:10.1007/s13555-026-01656-7

Blauvelt, Andrew; Hong, H Chih-Ho; Katoh, Norito; Langley, Richard G; Laquer, Vivian; Lesiak, Aleksandra; Peris, Ketty; Seneschal, Julien; Silvestre, Juan-Francisco; Warren, Richard B; Wollenberg, Andreas; Zirwas, Matthew; Bennike, Niels Højsager; Safavimanesh, Farzaneh; Tindberg, Ann-Marie; Reich, Kristian

发表日期：2026

文献求助收藏

Towards fibre-like loss for photonic integration from violet to near-infrared

面向紫光到近红外波段光子集成的类光纤损耗

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

特拉洛奇尤单抗治疗中重度特应性皮炎成人患者的疗效和安全性：III期试验的事后分析

Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis

tralokinumab治疗中重度特应性皮炎成人患者长达4年的疗效

Cutaneous adipose tissue carries a strong inflammatory signature in patients with psoriasis

银屑病患者的皮肤脂肪组织具有强烈的炎症特征。

Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer.

经皮碳酸氢盐缓冲疗法可提高膀胱癌肿瘤内pH值，并引发抗肿瘤反应。

High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?

高剂量、长半衰期IL-23抑制剂：银屑病治疗的下一个重大进展？

Poster Session I - A110 TRENDS IN SPENDING ON ADVANCED IBD THERAPIES PRESCRIBED BY GASTROENTEROLOGISTS IN MEDICARE

海报展示环节 I - A110 医疗保险中胃肠病学家开具的先进炎症性肠病 (IBD) 疗法支出趋势

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study

对 Amlitelimab STREAM-AD 2b 期研究中头颈部及其他身体部位特应性皮炎的事后分析

Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies

鲁索替尼乳膏按需单药治疗在轻度至中度特应性皮炎患者中显示出持续的疾病和症状控制：两项3期研究的汇总分析

Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特拉洛奇尤单抗治疗中重度特应性皮炎患者长达6年的长期安全性和有效性：开放标签扩展试验ECZTEND的最终结果